niacinamide has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is an orally administered active multikinase inhibitor for metastatic renal cell carcinoma that is now considered a standard agent." | 5.39 | Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma. ( Amoh, Y; Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mii, S, 2013) |
| "Sorafenib is an orally administered active multikinase inhibitor for metastatic renal cell carcinoma that is now considered a standard agent." | 1.39 | Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma. ( Amoh, Y; Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mii, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, M | 1 |
| Fujita, T | 1 |
| Amoh, Y | 1 |
| Mii, S | 1 |
| Matsumoto, K | 1 |
| Iwamura, M | 1 |
1 other study available for niacinamide and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.
Topics: Aged; Betamethasone; Carcinoma, Renal Cell; Fatal Outcome; Humans; Kidney Neoplasms; Male; Neoplasm | 2013 |